Hartnell et al. 1999 | Katsumori et al. 2020 | Molgaard et al. 1990 | |
---|---|---|---|
Selection | |||
Representativeness of exposed cohort | * | * | |
Selection of the non-exposed cohort | * | ||
Ascertainment of exposure | * | * | * |
Demonstration that outcomes of interest were not present at start of study | * | ||
Comparability | |||
Comparability of cohorts on the basis of the design or analysis controlled for confounders (other factors incl. Patient demographics, severity of disease, embolisation procedure) | ** | ||
Outcome | |||
Assessment of outcome | * | * | * |
Was follow-up long enough for outcomes to occur | * | * | * |
Adequacy of follow-up of cohorts | * | * | * |
Total Newcastle-Ottawa Score: | 5 | 8 | 5 |
AHRQ Judgement: | Poor quality | Good quality | Poor quality |